Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q2 2021 · 10-Q
Revenue$0.00$0.00— vs Q2 2020 Net Income-$1.85M-$1.85MN/M vs Q2 2020 EPS Diluted-$0.28-$0.28N/M vs Q2 2020 Operating Income-$1,749,406N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end